Jump Capital

Jump Capital is a venture capital firm founded in 2012 and headquartered in Chicago, Illinois, with additional offices in New York. The firm specializes in investing in data-driven technology companies, focusing on sectors such as FinTech, B2B SaaS, IT/Data Infrastructure, and Media. Jump Capital adopts a thesis-led and sector-focused approach, primarily targeting Seed and Series A stages. The firm emphasizes collaboration with talented management teams that value a trusted partner with operational expertise. Jump Capital typically makes initial investments ranging from $2 million to $10 million and provides extensive advocacy and support through a robust platform of institutional-level resources for entrepreneurs.

Sach Chitnis

General Partner and Co-Founder

Tarun Gupta

Vice President

Robert Hutchins

VP of Growth

Peter Johnson

Partner

Michael McMahon

General Partner and Co-Founder

Saaya Nath

Vice President

Yelena Shkolnik

Partner

Past deals in Missouri

Balto

Series B in 2024
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Balto

Series A in 2020
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

Balto

Seed Round in 2019
Balto Software Inc. is a developer of sales software that leverages artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform offers agents live guidance by alerting them to mistakes and providing suggestions tailored to specific products, phrases, and industry terminology. The software monitors conversations for compliance and quality, allowing representatives to self-correct in real time, while also equipping managers with tools to oversee key behaviors. Balto's solutions support various functions, including sales leadership, customer service, and compliance, and have guided over 150 million calls, resulting in substantial revenue increases and high customer ratings. The company is trusted by numerous contact centers, helping to prevent missed sales opportunities and improve customer experiences.

MediBeacon

Venture Round in 2013
MediBeacon Inc. is an optical diagnostic company focused on real-time kidney function monitoring solutions. Founded in 2012 and based in St. Louis, Missouri, the company offers the NIC-Kidney device to measure glomerular filtration rate (mGFR) in preclinical settings, alongside its advanced renal function system. This system utilizes an optical skin sensor paired with a proprietary fluorescent agent that activates in response to light, allowing continuous monitoring of kidney function. MediBeacon aims to enhance patient care by providing critical information that can improve outcomes in intensive care units and surgical environments. The company also has a diverse pipeline of light-activated agents, reflecting its commitment to advancing nephrology and various physiological monitoring applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.